O.L.M. Bijvoet

EFFECTS OF CALCITONIN ON PATIENTS WITH PAGET'S DISEASE, THYROTOXICOSIS, OR HYPERCALCÆMIA

O.L.M. Bijvoet, J. van der Sluys Veer, A.P. Jansen · The Lancet · 1968 · 176 citations

Medicine, Endocrinology, Pharmacotherapy +10

INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)

F.J.M. van Breukelen, O.L.M. Bijvoet, A.T. van Oosterom · The Lancet · 1979 · 172 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +8

Familial Benign Hypercalcaemia: STUDY OF A LARGE FAMILY

Fred H. Menko, O.L.M. Bijvoet, J. L. H. H. FRONEN et al. · QJM · 1983 · 43 citations

Medicine, Endocrinology, Surgery +16

THYROCALCITONIN IN PAGET'S DISEASE

O.L.M. Bijvoet, A.P. Jansen · The Lancet · 1967 · 42 citations

Medicine, Nephrology, Pathology +4

The renal tubular reabsorption of phosphate in thyrotoxicosis

O.L.M. Bijvoet, C.L.H. Majoor · Clinica Chimica Acta · 1965 · 16 citations

Medicine, Endocrinology, Nephrology +11